Thank you for registering your account
Thanks for joining touchIMMUNOLOGY to hear about news and updates from across the Immunology community.
We’ve sent you an email to verify your email address. Please click on the link to confirm your account.
You can review your email preferences at any time or update your account details
Women with axSpA: Navigating the childbearing years
Join Prof. Peter C Taylor as he discusses the unique challenges that women with axSpA face on their journey to motherhood.
- Recognize that prevalence, diagnosis, disease progression and treatment efficacy differ between men and women with axSpA
- Evaluate the unique challenges that exist for women of childbearing age with axSpA
- Discuss optimal treatment strategies for women of childbearing age with axSpA
Eosinophilic inflammatory diseases of the respiratory system: New therapeutic options
Watch a panel of experts discuss how to identify and manage patients with inflammatory respiratory diseases, with a focus on severe eosinophilic asthma.
- Recognize the role of eosinophils and type 2 inflammation in respiratory disease
- Understand the diagnostic methods used to differentiate inflammatory diseases of the respiratory system
- Recall disease states that may benefit from therapies that target the complex interaction between eosinophils and their environment
Amy S. Paller, AAD VMX: Advances in the Treatment of Atopic Dermatitis in Children
Following the AAD VMX meeting we caught up with Prof. Amy S. Paller (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) to discuss some of the presentations and recent advances being made in the treatment of children with atopic dermatitis. Disclosures: Prof. Amy Paller has acted as a consultant with honorarium for AbbVie, Abeona, […]
Stefan Schreiber, ECCO 2021: Filgotinib for the Treatment of Ulcerative Colitis
TouchIMMUNOLOGY had the pleasure of talking to Professor Stefan Schreiber (University Hospital Schleswig-Holstein, Kiel, Germany) around the efficacy and safety findings from the SELECTION study and its long term extension. The abstract ‘Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study.‘ (OP04) was […]
Birgit Weinberger, EAACI 2021: The Importance of Vaccination in the Older Population
TouchIMMUNOLOGY joins Dr Birgit Weinberger (Institute for Biomedical Aging Research, University of Innsbruck, Innsbruck, Austria) at EAACI 2021 to discuss the benefits and limitations of vaccinations in the older population. Questions What is known about the severity of infection and immunogenicity of vaccines in older adults? (0:20) What evidence supports the use of increased antigen […]
Andy Blauvelt, EADV 2021: Switching from Dupilumab to Upadacitinib in Atopic Dermatitis
It was a pleasure to speak with Dr Andy Blauvelt (Oregon Medical Research Center, Portland, OR, USA) about the results from the recent open-label study investigating the efficacy and safety of switching from dupilumab to upadacitinib in the treatment of atopic dermatitis. His presentation entitled ‘Efficacy and Safety of Switching from Dupilumab to Upadacitinib in […]
Letter from the Editor-in-Chief
touchREVIEWS in RMD. 2021;1:Online ahead of journal publication
Dear readers I am delighted to take on the mantle of Editor-in-Chief for touchREVIEWS in RMD and am grateful to have this opportunity to share some details of my background and my passion for great medical education with you. My first job after leaving school was to work (very briefly) for an estate agent in […]